Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply
N Engl J Med
.
2019 May 2;380(18):e32.
doi: 10.1056/NEJMc1902336.
Authors
Marie Scully
1
,
Jessica Minkue Mi Edou
2
,
Filip Callewaert
3
Affiliations
1
UCLH/UCL Biomedical Research Centre, London, United Kingdom.
2
Ablynx, Zwijnaarde, Belgium.
3
Sanofi, Diegem, Belgium.
PMID:
31042847
DOI:
10.1056/NEJMc1902336
No abstract available
Publication types
Letter
Comment
MeSH terms
ADAMTS13 Protein
Humans
Purpura, Thrombotic Thrombocytopenic*
Single-Domain Antibodies*
Substances
Single-Domain Antibodies
caplacizumab
ADAMTS13 Protein